Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12609001054202
Ethics application status
Approved
Date submitted
2/12/2009
Date registered
9/12/2009
Date last updated
12/06/2012
Type of registration
Retrospectively registered
Titles & IDs
Public title
Electroacupuncture for Chemotherapy Induced Nausea and Vomiting.
Query!
Scientific title
Electroacupuncture versus Sham Acupuncture and no Acupuncture for the Control of Acute and Delayed Chemotherapy Induced Nausea and Vomiting in patients with solid tumors.
Query!
Secondary ID [1]
1186
0
nil
Query!
Universal Trial Number (UTN)
U1111-1112-6845
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cancer - solid tumors
252329
0
Query!
Chemotherapy induced nausea and vomiting
252330
0
Query!
Condition category
Condition code
Cancer
252515
252515
0
0
Query!
Other cancer types
Query!
Alternative and Complementary Medicine
252516
252516
0
0
Query!
Other alternative and complementary medicine
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Electroacupuncture,
Electroacupuncture at 4 acupuncture points bilaterally indicated for nausea and vomiting. Points are PC6, ST36, LV 3 and LI4. Sensi sterile acupuncture needles 0.20 x 30mm inserted and manipulated until "deqi" or a sensation is obtained. The frequency of the stimulation will be 10Hz and the intensity will be adjusted according to patient's tolerance (maximum 10 mA). Treatment will commence 10 minutes prior to chemotherapy starting and continue for further 20mins and will be repeated on Day 3. Patients recieve standard antiemetics as per protocols.
Query!
Intervention code [1]
255638
0
Treatment: Other
Query!
Comparator / control treatment
Sham acupuncture
Sham acupuncture will inserted adjacent to the true acupuncture point bya defined distance. Once the needles are inserted no further manipulation occurs. The electroacupuncture unit will be connected but will be non-functioning. Treatment is repeated on Day 3.
Contol Arm
Patients will receive standard treatment ie. normal antiemetic therapy and no acupunture.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
253405
0
Functional Living Index - Emesis score Day 7
Query!
Assessment method [1]
253405
0
Query!
Timepoint [1]
253405
0
Pre chemotherapy and Day 7 of chemotherapy treatment
Query!
Secondary outcome [1]
262495
0
Functional Living Index - Emesis score at day 4
Query!
Assessment method [1]
262495
0
Query!
Timepoint [1]
262495
0
Pre chemotherapy and Day 4 of chemotherapy treatment
Query!
Secondary outcome [2]
262496
0
Number of vomits day 1 -6 recorded in the daily patient diary.
Query!
Assessment method [2]
262496
0
Query!
Timepoint [2]
262496
0
Day 1, 2, 3, 4, 5 and 6 of chemotherapy treatment.
Query!
Secondary outcome [3]
262497
0
Nausea score Visual Analogue Scale (VAS) days 1-6 of chemotherapy treatment.
Query!
Assessment method [3]
262497
0
Query!
Timepoint [3]
262497
0
Day 1, 2, 3, 4, 5 and 6 of chemotherapy treatment.
Query!
Secondary outcome [4]
262498
0
Number of patients returning on Day 3.
Query!
Assessment method [4]
262498
0
Query!
Timepoint [4]
262498
0
Day 3 of chemotherapy treatment.
Query!
Secondary outcome [5]
262499
0
Number of patients recruited in 6 months
Query!
Assessment method [5]
262499
0
Query!
Timepoint [5]
262499
0
Assess at 6 months following enrolment of first patient.
Query!
Secondary outcome [6]
262500
0
Toxicity of acupuncture using modified National Cancer Institute Toxicity scale.
Query!
Assessment method [6]
262500
0
Query!
Timepoint [6]
262500
0
Assessed on Day 1, 3 and 7 for treatment arms
Query!
Eligibility
Key inclusion criteria
18 years and older
Receiving moderate to highly emetogenic chemotherapy.
Chemotherapy naive.
Solid tumors ( no haematological malignant disease)
A good understanding of English
Cognitive ability allowing for fully informed written consent and to complete all trial questionaires.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
History of acute, chronic or sub acute ileus
With thrombocytopenia (defined as platelet count <100)
Previous acupuncture for nausea and vomiting
Pre-existing nausea or vomiting from another medical condition.
Participating in any other trial, including those of new chemotherapy regimens
Concurrent treatment of chemotherapy and radiotherapy
Needle phobias
Insufficient understanding of the trial and its requirements
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Patient allocation was done by sealed opaque envelope.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by using a computerised sequence generator program
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/04/2009
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Funding & Sponsors
Funding source category [1]
256121
0
Charities/Societies/Foundations
Query!
Name [1]
256121
0
Mater Foundation
Query!
Address [1]
256121
0
Stanley Street,
South Brisbane, Qld 4101.
Query!
Country [1]
256121
0
Australia
Query!
Funding source category [2]
256122
0
Commercial sector/Industry
Query!
Name [2]
256122
0
Australian Acupuncture and Chinese Medicine Assosciation
Query!
Address [2]
256122
0
Unit 1, 55 Clarence Street
COORPAROO QLD 4151
Query!
Country [2]
256122
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Mater Adults Hospital
Query!
Address
Raymond Terrace
South Brisbane, Qld 4101
Query!
Country
Australia
Query!
Secondary sponsor category [1]
251465
0
University
Query!
Name [1]
251465
0
University of Western Sydney
Query!
Address [1]
251465
0
Narellan Road
Campbelltown NSW 2560
Query!
Country [1]
251465
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
258214
0
Mater Health Services Human Research Ethics Committee
Query!
Ethics committee address [1]
258214
0
Level 2 Aubigny Place Raymond Tce South Brisbane Qld 4101
Query!
Ethics committee country [1]
258214
0
Australia
Query!
Date submitted for ethics approval [1]
258214
0
15/10/2008
Query!
Approval date [1]
258214
0
25/02/2009
Query!
Ethics approval number [1]
258214
0
1276A
Query!
Summary
Brief summary
To test the benefit of using electroacupuncture for chemotherapy induced nausea and vomiting. Specifically test if electroacupuncture has a benefit in delayed chemotherapy induced nausea and vomiting, which is defined as after the first 24hours post chemotherapy. Even with our new antiemetic drugs and protocols patient’s still experience nausea and vomiting and is identified as one of the major concerns for patients undergoing chemotherapy. The trial will address areas that need to be investigated as identified by Ezzo et al 2005 in a Cochrane Collaborative Review. These include obtaining data on the effectiveness of electroacupuncture with modern antiemetics, utilising more than one acupuncture point and getting data on delayed nausea and vomiting.
Query!
Trial website
Query!
Trial related presentations / publications
Presented at Australian Acupuncture and Chinese Medicine Associations Annual Conference, Brisbane, May 2012
Query!
Public notes
Query!
Contacts
Principal investigator
Name
30571
0
Query!
Address
30571
0
Query!
Country
30571
0
Query!
Phone
30571
0
Query!
Fax
30571
0
Query!
Email
30571
0
Query!
Contact person for public queries
Name
13818
0
Mr Chris McKeon
Query!
Address
13818
0
Level 10 Day Oncology Unit
Mater Adults Hospital
Raymond Terrace
South Brisbane Qld 4101
Query!
Country
13818
0
Australia
Query!
Phone
13818
0
+61(0)7 31631952
Query!
Fax
13818
0
Query!
Email
13818
0
[email protected]
Query!
Contact person for scientific queries
Name
4746
0
Mr Chris McKeon
Query!
Address
4746
0
Level 10 Day Oncology Unit
Mater Adults Hospital
Raymond Terrace
South Brisbane Qld 4101
Query!
Country
4746
0
Australia
Query!
Phone
4746
0
+61 (0)731631952
Query!
Fax
4746
0
Query!
Email
4746
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
EA versus sham acupuncture and no acupuncture for the control of acute and delayed chemotherapy-induced nausea and vomiting: a pilot study.
2015
https://dx.doi.org/10.1136/acupmed-2015-010781
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF